EPHB2 Recombinant antibody

EPHB2 Recombinant Antibody for WB, ELISA
Cat No. 83277-1-RR
Clone No.230111A5

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

WB, ELISA

EK5, EC:2.7.10.1, DRT, Developmentally-regulated Eph-related tyrosine kinase, CAPB

Formulation:  PBS and Azide
PBS and Azide
PBS Only
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:


Tested Applications

Positive WB detected inHepG2 cells, U-251 cells
Positive FC (Intra) detected inHepG2 cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:1000
Flow Cytometry (FC) (INTRA)FC (INTRA) : 0.25 ug per 10^6 cells in a 100 µl suspension
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Published Applications

WBSee 1 publications below

Product Information

83277-1-RR targets EPHB2 in WB, ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Recombinant
Type Antibody
Immunogen EPHB2 fusion protein Ag28786 Predict reactive species
Full Name EPH receptor B2
Calculated Molecular Weight 987 aa, 108 kDa
Observed Molecular Weight 120 kDa
GenBank Accession NumberBC018763
Gene Symbol EPHB2
Gene ID (NCBI) 2048
RRIDAB_3670947
Conjugate Unconjugated
Form Liquid
Purification MethodProtein A purfication
UNIPROT IDP29323
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol , pH 7.3
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Protocols

Product Specific Protocols
WB protocol for EPHB2 antibody 83277-1-RRDownload protocol
FC protocol for EPHB2 antibody 83277-1-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB

J Exp Clin Cancer Res

tsRNA-GlyGCC promotes colorectal cancer progression and 5-FU resistance by regulating SPIB

Authors - Rong Xu
Loading...